Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Derek Buck

Physical Medicine & Rehabilitation Bluefield, VA Medical Doctor

NPI 1790951432 CMS profile 81620

111E Sanders Ln, Bluefield, VA 24605

Open in the dashboard

General payments

$7,169

132 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Derek Buck of Bluefield, VA is reported in the CMS Open Payments database as having received $7,169 across 132 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $477 16
2024 General $1,202 33
2023 General $3,859 35
2022 General $537 10
2021 General $687 13
2020 General $120 7
2019 General $287 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Derek Buck
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Derek Buck were reported at $477. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Derek Buck Physical Medicine & Rehabilitation median Middle half National median
2019 $287 $133 $45–$390 $163
2020 $120 $88 $29–$272 $114
2021 $687 $116 $33–$360 $132
2022 $537 $123 $40–$378 $149
2023 $3,859 $131 $43–$396 $160
2024 $1,202 $141 $45–$409 $164
2025 $477 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $3,843 102 payments
  2. Relievant Medsystems, Inc. $2,963 13 payments
  3. DePuy Synthes Sales Inc. $73 5 payments
  4. Trice Medical, Inc. $67 1 payment
  5. Stryker Corporation $56 2 payments
  6. Nalu Medical, Inc. $53 2 payments
  7. Abbott Laboratories $24 1 payment
  8. Fidia Pharma USA Inc. $19 1 payment
  9. Medtronic, Inc. $17 1 payment
  10. Vertex Pharmaceuticals Incorporated $16 1 payment
  11. Other $38 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,958 126 payments
  2. Travel and Lodging $2,211 6 payments
Products named General payments · program years 2019–2025
  1. Intracept Pain $2,963 13 payments
  2. Intracept Pain $2,963 13 payments
  3. Intracept Pain $2,963 13 payments
  4. Intracept Pain $2,963 13 payments
  5. GENERAL PAIN MANAGEMENT $730 15 payments
  6. WaveWriter Alpha Prime 16 $679 19 payments
  7. General - Pain Management $461 12 payments
  8. Infinion 16 $355 7 payments
  9. CoverEdge 32 $142 2 payments
  10. Vercise $98 3 payments
  11. Other $816 38 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

353

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$3,778

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

32.6%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 78 $1,026
Pregabalin Generic 26 $847
Celecoxib Generic 20 $394
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 24 $335
Oxycodone Hcl Generic 55 $254
Acetaminophen-Codeine Acetaminophen With Codeine Brand 13 $171
Gabapentin Generic 34 $164
Methylprednisolone Generic 23 $155
Diclofenac Sodium Generic 11 $153
Tizanidine Hcl Generic 27 $146

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 39 billing codes

Paid by Medicare

$92,718

Medicare's payments for the services billed

Medicare patients

384

Average age 72

Services billed

1,338

242 women, 142 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Osteoporosis 33%
Depression 27%
Diabetes 25%
Ischemic heart disease 21%
COPD 19%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

132 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record